CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Inc., (NASDAQ: GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that it will show a prototype of the Company’s NexGen system, an all-electronic fully integrated molecular diagnostics platform, at the Association of Molecular Pathology (AMP) meeting to be held on October 25-27, 2012 in Long Beach, California.
